CIBC Asset Management Inc Has $4.66 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

CIBC Asset Management Inc grew its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 7.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,107 shares of the medical instruments supplier’s stock after buying an additional 224 shares during the period. CIBC Asset Management Inc’s holdings in Mettler-Toledo International were worth $4,660,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Family Firm Inc. bought a new position in shares of Mettler-Toledo International in the second quarter worth about $25,000. Blue Trust Inc. increased its stake in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares during the period. Ashton Thomas Securities LLC bought a new position in shares of Mettler-Toledo International in the third quarter worth about $37,000. Rothschild Investment LLC bought a new position in shares of Mettler-Toledo International in the second quarter worth about $42,000. Finally, Itau Unibanco Holding S.A. bought a new position in shares of Mettler-Toledo International in the second quarter worth about $42,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Evercore ISI boosted their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. JPMorgan Chase & Co. boosted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Finally, Stifel Nicolaus decreased their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $1,338.75.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,179.58 on Monday. The business’s 50 day simple moving average is $1,382.02 and its 200-day simple moving average is $1,402.37. Mettler-Toledo International Inc. has a one year low of $1,041.49 and a one year high of $1,546.93. The company has a market capitalization of $24.89 billion, a P/E ratio of 31.80, a PEG ratio of 3.89 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.